DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
- Submitting institution
-
University of Sussex
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 213429_65727
- Type
- D - Journal article
- DOI
-
10.1182/blood-2015-11-684225
- Title of journal
- Blood
- Article number
- -
- First page
- 971
- Volume
- 128
- Issue
- 7
- ISSN
- 0006-4971
- Open access status
- Other exception
- Month of publication
- June
- Year of publication
- 2016
- URL
-
http://dx.doi.org/10.1182/blood-2015-11-684225
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
15
- Research group(s)
-
-
- Citation count
- 58
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the design and conduct of the study and critiqued the output for important intellectual content.
- Non-English
- No
- English abstract
- -
